GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Market Cap

Nanexa AB (OSTO:NANEXA) Market Cap : kr213.40 Mil (As of Apr. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Nanexa AB's share price for the quarter that ended in Dec. 2024 was kr2.16. Nanexa AB's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 135.70 Mil. Therefore, Nanexa AB's market cap for the quarter that ended in Dec. 2024 was kr293.10 Mil.

Nanexa AB's quarterly market cap increased from Jun. 2024 (kr123.21 Mil) to Sep. 2024 (kr238.15 Mil) and increased from Sep. 2024 (kr238.15 Mil) to Dec. 2024 (kr293.10 Mil).

Nanexa AB's annual market cap increased from Dec. 2022 (kr140.43 Mil) to Dec. 2023 (kr166.91 Mil) and increased from Dec. 2023 (kr166.91 Mil) to Dec. 2024 (kr293.10 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Nanexa AB's Enterprise Value for Today is kr206.81 Mil.


Nanexa AB Market Cap Historical Data

The historical data trend for Nanexa AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Market Cap Chart

Nanexa AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 251.50 202.78 140.43 166.91 293.10

Nanexa AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.91 105.30 123.21 238.15 293.10

Competitive Comparison of Nanexa AB's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Nanexa AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanexa AB's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nanexa AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Nanexa AB's Market Cap falls into.


;
;

Nanexa AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Nanexa AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=kr2.16*135.696
=kr293.10

Nanexa AB's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=kr2.16*135.696
=kr293.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanexa AB  (OSTO:NANEXA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Nanexa AB Market Cap Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanexa AB Business Description

Traded in Other Exchanges
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its products and also has collaboration agreements with several pharma companies, among others AstraZeneca. Geographically, the company derives maximum revenue from Nordic countries.

Nanexa AB Headlines

No Headlines